Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Cabergoline Treatment Report
What is Cabergoline?

Cabergoline is an ergot-derived dopamine agonist used in the treatment of Parkinson's disease. Due to elevated levels of heart problems, ergot-derived agonists are being phased out of clinical use.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat Parkinson's 4 3
Treat Parkinson's disease 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 33%
Moderate
0 0%
Mild
2 67%
None
0 0%

Most commonly reported side effects

sudden sleep
1 33%
low blood pressure
1 33%
tiredness
1 33%
Obsessive compulsive disorder OCD
1 33%
Skin rash
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 0.5 mg daily 4 mg daily 8 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Cabergoline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
4 100% Doctor's advice: 100%

See all 4 patients who’ve stopped taking Cabergoline

Currently Taking Cabergoline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
2

Stopped Taking Cabergoline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
2
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
3 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 33%
A little
0 0%
Not at all
2 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.